Skip to content
HowShorted

ARROWHEAD PHARMACEUTICALS, INC. short interest in 2018

In 2018, ARROWHEAD PHARMACEUTICALS, INC.'s disclosed short interest ran from 5.99% of shares outstanding on 12 Jan 2018 to 19.99% on 31 Dec 2018, a change of +14.00 percentage points. The year's high was 19.99% on 31 Dec 2018 and its low 5.03% on 31 Jan 2018, averaging 12.48% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 13.37 days on 30 Nov 2018. Full history: ARROWHEAD PHARMACEUTICALS, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for ARROWHEAD PHARMACEUTICALS, INC. in 2018

2018 in figures

Start of year
5.99% (12 Jan 2018)
End of year
19.99% (31 Dec 2018)
Change
+14.00 pp
High
19.99% (31 Dec 2018)
Low
5.03% (31 Jan 2018)
Average
12.48%
Highest days to cover
13.37 (30 Nov 2018)
SEC filings marked
8

Every report in 2018

ARROWHEAD PHARMACEUTICALS, INC. short interest in 2018
SettlementShort interestDays to coverFilings since previous
12 Jan 20185.99%1.32
31 Jan 20185.03%1.69
15 Feb 20185.39%3.1310-Q filed, results (8-K)
28 Feb 20185.35%3.07
15 Mar 20186.07%2.68
29 Mar 20187.72%2.96
13 Apr 20188.82%5.22
30 Apr 20189.08%9.23
15 May 20187.23%3.0310-Q filed, results (8-K)
31 May 20187.28%4.17
15 Jun 20188.53%5.00
29 Jun 201813.16%3.31
13 Jul 201814.08%7.34
31 Jul 201815.53%6.42
15 Aug 201815.72%9.7510-Q filed, results (8-K)
31 Aug 201816.47%11.40
14 Sep 201816.45%2.80
28 Sep 201817.48%12.09
15 Oct 201819.47%3.69
31 Oct 201818.36%8.92
15 Nov 201818.71%8.62
30 Nov 201819.55%13.37
14 Dec 201818.01%9.8310-K filed, results (8-K)
31 Dec 201819.99%9.09

See also: ARROWHEAD PHARMACEUTICALS, INC.'s full history · most shorted US stocks of 2018 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.